Komori
Semiannual Report7459MEDIPAL HOLDINGS CORPORATIONWholesale Trade

Semiannual Report — FY2026 H1

What MEDIPAL HOLDINGS CORPORATION reported for the period from 2026-04-01 to 2027-03-31.

How much it says
61Detailed
What moved here
10named for the first time
Its own wording
11terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the interim period, revenue increased mainly in the wholesale business for prescription pharmaceuticals and other products. Operating profit declined, while interim net income attributable to owners of the parent increased. In addition, the accounting treatment for the business combination with SigNi Holdings was finalized, and PALTAC progressed toward becoming a wholly owned subsidiary through the tender offer and share sale demand.

Komori's summary of this document, not the document's own words.
61Detailed
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 36 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
93
Very detailed
Magnitude of change
31
Thin
Strategic shift
97
Very detailed
Capital movements
75
Very detailed
Disclosure gaps
12
Almost nothing
Changes in risk
77
Very detailed
Financial and capital policy
100
Very detailed
Specificity of disclosure
0
Almost nothing
Product portfolio
0
Almost nothing
Technology position
100
Very detailed
Confidence in strategic bets
R&D spend15億円Money spent making new things.
Cash left over84億円Cash from the business, less what went into equipment.
Spent on equipment122億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
MEDIPAL HOLDINGS CORPORATION — FY2026 H1 | Komori